Published in Eur Urol on January 28, 2015
The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur Urol (2013) 3.43
Predicting Renal Function Outcomes After Partial and Radical Nephrectomy. Eur Urol (2018) 2.66
Renal Ischemia and Function After Partial Nephrectomy: A Collaborative Review of the Literature. Eur Urol (2015) 2.23
Predicting survival of patients with node-positive prostate cancer following multimodal treatment. Eur Urol (2013) 2.16
Current perspectives in the use of molecular imaging to target surgical treatments for genitourinary cancers. Eur Urol (2013) 2.04
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy. Eur Urol (2015) 1.74
Prediction of outcome following early salvage radiotherapy among patients with biochemical recurrence after radical prostatectomy. Eur Urol (2013) 1.63
Survivorship and improving quality of life in men with prostate cancer. Eur Urol (2015) 1.53
Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus. BJU Int (2015) 1.47
Impact of Early Salvage Radiation Therapy in Patients with Persistently Elevated or Rising Prostate-specific Antigen After Radical Prostatectomy. Eur Urol (2017) 1.38
A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int (2014) 1.06
Cryoablation for Small Renal Masses: Selection Criteria, Complications, and Functional and Oncologic Results. Eur Urol (2015) 1.01
Higher expression of topoisomerase II alpha is an independent marker of increased risk of cancer-specific death in patients with clear cell renal cell carcinoma. Eur Urol (2013) 0.95
Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome. Mod Pathol (2013) 0.94
Mayo adhesive probability score: an accurate image-based scoring system to predict adherent perinephric fat in partial nephrectomy. Eur Urol (2014) 0.88
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes. Eur Urol (2015) 0.88
Predicting survival of men with recurrent prostate cancer after radical prostatectomy. Eur J Cancer (2015) 0.81
Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy. Eur Urol (2015) 0.79
Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness. Eur Urol (2016) 0.78
Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. Eur Urol (2015) 0.78
Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy. Eur Urol (2016) 0.77
TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol (2017) 0.76
The impact of histology on survival for patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Indian J Urol (2014) 0.76
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol (2016) 0.76
Radiographic size of retroperitoneal lymph nodes predicts pathological nodal involvement for patients with renal cell carcinoma: development of a risk prediction model. BJU Int (2016) 0.75
BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor. BMC Urol (2017) 0.75
Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol (2016) 0.75
Outcomes After Cryoablation Versus Partial Nephrectomy for Sporadic Renal Tumors in a Solitary Kidney: A Propensity Score Analysis. Eur Urol (2017) 0.75
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int (2016) 0.75
Radical Nephrectomy With or Without Lymph Node Dissection for High-Risk Non-Metastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol (2017) 0.75
Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int (2017) 0.75
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients. Eur Urol (2016) 0.75
Observations on transatlantic renal cell cancer surgery outcomes. BJU Int (2015) 0.75
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection. Eur Urol (2017) 0.75
Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study. Eur Urol (2019) 0.75
Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol (2017) 0.75
Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. Eur Urol (2016) 0.75
Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. Eur Urol (2016) 0.75
Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis. Eur Urol (2017) 0.75
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis. Eur Urol (2017) 0.75
Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancer. BJU Int (2016) 0.75
Comprehensive assessment of renal tumour complexity in a large percutaneous cryoablation cohort. BJU Int (2017) 0.75
Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Eur Urol (2014) 0.75
Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol (2017) 0.75
Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma. Eur Urol Focus (2016) 0.75
Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma. BJU Int (2016) 0.75